MITO CERV 2

Trial Description: 
Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer
Lead Cooperative Group: 
Disease Site: 
Cervical
Trial Status: 
Completed
Contact person: